Quality of life with nonpharmacologic treatment of hypertension

Current Hypertension Reports

Volumn 3, Issue 6, 2001, Pages 466-472

  Roel, Joseph P ^a   Hildebrant, Carrie L ^a   Grimm Jr , Richard H ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; DIET THERAPY; HUMAN; HYPERTENSION; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; RISK FACTOR; SODIUM RESTRICTION; TREATMENT OUTCOME; WEIGHT REDUCTION;

BLOOD PRESSURE; DIET, SODIUM-RESTRICTED; HUMAN; HYPERTENSION; QUALITY OF LIFE; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 0035656229     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-001-0008-8     Document Type: Article

References (49)

1. Williams G: Assessing patient wellness: new perspectives on quality of life and compliance. Am J Hypertens 1998, 11:186S-191S.
2. Burt VL, Whelton P, Roccella E.J., et al.: Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Study, 1988-1991. Hypertension 1995, 25:305-313.
3. Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997, 157:2413-2446.
4. Stamler J, Stamler R, Neaton J: Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993, 153:598-615.
5. Testa M: Methods and applications of quality-of-life measurement during antihypertensive therapy. Curr Hypertens Rep 2000, 2:530-537.
6. Nelsen L, Himmelberger D, Morrison A., et al.: Quality-of-life questionnaire for patients taking antihypertensive medication. Clin Ther 1999, 21:177-183.
7. Adverse reactions to bendrofluazide and propanolol for the treatment of mild hypertension: report of Medical Research Council Working Party on Mild to Moderate Hypertension. Lancet 1981, 2:539-543.
8. Solomon S, Hotchkiss E, Saravay S., et al.: Impairment of memory function by antihypertensive medication. Arch Gen Psychiatry 1983, 40:1109-1112.
9. Hunt S: Quality of life claims in trials of antihypertensive therapy. Qual Life Res 1997, 6:185-191.
10. Hjemdahl P, Wiklund I: Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise? J Hypertens 1992, 10:1437-1446.
11. Haynes R, Sackett D, Taylor D: Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med 1978, 299:741-744.
12. Hollenberg N, Testa M, Williams G: Quality of life as a therapeutic end-point: an analysis of therapeutic trials in hypertension. Drug Saf 1991, 6:83-93.
13. Os I: Quality of life in hypertension. J Hum Hypertens 1994, 8(SUPPL. 1):S27-S30.
14. Hatton D, Haynes R, Oparil S., et al.: Improved quality of life in patients with generalized cardiovascular metabolic disease on a prepared diet. Am J Clin Nutr 1996, 64:935-943.
15. Plaisted C, Lin P-H, Ard J, et al: The effects of dietary patterns on quality of life: a substudy of the Dietary Approaches to Stop Hypertension trial. J Am Diet Assoc 1999, 99(Suppl):S84-S89.
16. McInnes G: Integrated approaches to management of hypertension: promoting treatment acceptance. Am Heart J 1999, 138:S252-S255.
17. Grimm R: Antihypertensive treatment comparison trials: quality-of-life effects. In Hypertension Primer. Edited by Izzo J, Black H. Dallas: American Heart Association; 1993:202-204.
18. Bulpitt C, Dollery C, Carne S: Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 1976, 38:121-128.
19. Bergner M, Bobbitt R, Carter W., et al.: The Sickness Impact Profile: development and final version of a health status measure. Med Care 1981, 19:787-805.
20. Bulpitt C: Quality of life as an outcome measure. Postgrad Med J 1997, 73:613-616.
21. Ware J, Snow K, Kosinski M., et al.: SF-36 Health Survey Manual and Interpretation Guide. Boston: New England Medical Center; 1993.
22. Halbert J, Silagy C, Finucane P., et al.: Physical activity and cardiovascular risk factors: Effect of advice from an exercise specialist in Australian general practice. Med J Aust 2000, 173:84-87.
23. Grimm RH J.r., Grandits GA, Cutler J.A., et al.: Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med 1997, 157:638-648.
24. Hansson L, Zanchetti A, Carruthers S.G., et al.: Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998, 351:1755-1762.
25. Hansson L, Zanchetti A, for the HOT Study Group: The Hypertension Optimal Treatment (HOT) study: 24-month data on blood pressure and tolerability. Blood Press 1997, 6:313-317.
26. Myers M: Compliance in hypertension: why don't patients take their pills? Can Med Assoc J 1999, 160:64-65.
27. Stamler R, Stamler J, Grimm R: Nutritional therapy for high blood pressure: final report of a four-year randomized controlled trial: the Hypertension Control Program. JAMA 1987, 257:1484-1491.
28. Whelton P, Kumanyika S, Cook N., et al.: Efficacy of nonphar-macologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Am J Clin Nutr 1997, 65(Suppl):652S-660S.
29. Hollenberg N, Williams G, Anderson R: Medical therapy, symptoms, and the distress they cause. Arch Intern Med 2000, 160:1477-1483.
30. Working Group on Primary Prevention of Hypertension: Report of the National High Blood Pressure Education Program Working Group on Primary Prevention of Hypertension. Arch Intern Med 1993, 153:186-208.
31. Barr S, McCarron D, Heaney R., et al.: Effects of increased consumption of fluid milk on energy and nutrient intake, body weight, and cardiovascular risk factors in healthy older adults. J Am Diet Assoc 2000, 100:810-817.
32. Fuster V, Pearson T: 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events, September 14-15, 1995. J Am Coll Cardiol 1996, 27:957-1047.
33. Kokkinos P, Papademetriou V: Exercise and hypertension. Coronary Artery Dis 2000, 11:99-102.
34. Metz J, Stern J, Kris-Etherton P, et al.: A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients. Arch Intern Med 2000, 160:2150-2158.
35. Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure: The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993, 153:154-183.
36. Appel L, Moore T, Obarzanek E., et al.: A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997, 336:1117-1124.
37. Sacks F, Svetkey L, Vollmer W., et al.: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001, 344:3-10.
38. Kumanyika S, Hebert P, Cutler J., et al.: Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, Phase 1. Hypertension 1993, 22:502-512.
39. Stevens V, Corrigan S, Obarzanek E., et al.: Weight loss intervention experience in Phase 1 of the Trials of Hypertension Prevention. Arch Intern Med 1993, 153:849-858.
40. Cook N, Kumanyika S, Cutler J: Effect of change in sodium excretion on change in blood pressure corrected for measurement error. The Trials of Hypertension Prevention, Phase I. Am J Epidemiol 1998, 148:431-444.
41. Stevens V, Obarzanek E, Cook N., et al.: Long-term weight loss in blood pressure: results of the Trials of Hypertension Prevention, Phase II. Ann Intern Med 2001, 134:1-11.
42. Anderson R, Hogan P, Appel L., et al.: Baseline correlates with quality of life among men and women with medication-controlled hypertension: The Trial of Nonpharmacologic Interventions in the Elderly (TONE). J Am Geriatr Soc 1997, 45:1080-1085.
43. Whelton P, Bahnson J, Appel L., et al.: Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly. J Am Geriatr Soc 1997, 45:185-193.
44. Appel L, Espeland M, Whelton D., et al.: Trial of Non-Pharma-cological Intervention in the Elderly (TONE): design and rationales of a blood pressure control trial. Ann Epidemiol 1995, 5:119-129.
45. Whelton PK, Appel LJ, Espeland M.A., et al.: Sodium reduction and weight loss in the treatment of hypertension in older persons: A randomized controlled Trial of Nonpharmacologic Interventions in the Elderly (TONE). JAMA 1998, 279:839-846.
46. Pandya D, Vyas V, Vyas S: Mind-body therapy in the management and prevention of coronary disease. Comprehensive Ther 1999, 25:283-293.
47. Fletcher A: Quality of life in the management of hypertension. Clin Exp Hypertens 1999, 21:961-972.
48. Traeden U, Holm L, Sandstrom B., et al.: Effectiveness of a dietary intervention strategy in general practice: Effects on blood lipids, health and well-being. Public Health Nutr 1998, 1:273-281.
49. McCarron D, Oparil S, Resnick L., et al.: Comprehensive nutrition plan improves cardiovascular risk factors in essential hypertension. Am J Hypertens 1998, 11:31-40.